PubRank

M Camilleri

Author PubWeight™ 272.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997 2.71
2 Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987 2.46
3 Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther 2002 2.37
4 Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil 2004 2.28
5 Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci 1989 2.23
6 Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology 1986 2.03
7 Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007 1.98
8 Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991 1.98
9 Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000 1.93
10 Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol 1990 1.90
11 A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003 1.85
12 Is there a role for gastric accommodation and satiety in asymptomatic obese people? Obes Res 2001 1.84
13 Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol 1985 1.81
14 Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997 1.80
15 Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986 1.79
16 Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther 2012 1.79
17 Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology 2000 1.74
18 Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil 2009 1.73
19 Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil 2011 1.72
20 Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2004 1.72
21 Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology 2001 1.64
22 Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology 1991 1.63
23 Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 2004 1.63
24 Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000 1.61
25 A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005 1.60
26 Adrenergic modulation of human colonic motor and sensory function. Am J Physiol 1997 1.59
27 [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology 1997 1.59
28 Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984 1.59
29 Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc 1995 1.58
30 SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography. Gut 2002 1.58
31 Development of a test to measure gastric accommodation in humans. Am J Physiol 1999 1.56
32 Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med 1997 1.54
33 Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut 2003 1.53
34 Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol 1998 1.51
35 Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil 2009 1.51
36 The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology 1995 1.50
37 Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986 1.49
38 Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria. J Clin Gastroenterol 1992 1.48
39 Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 1994 1.47
40 Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 2008 1.47
41 Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc 1992 1.46
42 Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology 1995 1.46
43 Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000 1.45
44 Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med 1993 1.45
45 Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999 1.42
46 Gastrointestinal manifestations of systemic vasculitis. Q J Med 1983 1.41
47 Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology 1992 1.41
48 Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil 2004 1.40
49 Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 2003 1.39
50 Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut 1994 1.37
51 Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol 2001 1.36
52 Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil 2009 1.35
53 Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil 2009 1.32
54 American Gastroenterological Association medical position statement on anorectal testing techniques. American Gastroenterological Association. Gastroenterology 1999 1.32
55 Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut 1999 1.31
56 Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol 1995 1.30
57 Descending perineum syndrome: audit of clinical and laboratory features and outcome of pelvic floor retraining. Am J Gastroenterol 1999 1.30
58 Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2001 1.29
59 Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil 2009 1.29
60 Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol 2001 1.28
61 Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut 1995 1.25
62 Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol 1998 1.24
63 Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 2001 1.23
64 Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut 2000 1.23
65 Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999 1.22
66 Variation of muscle tone in the human colon. Gastroenterology 1991 1.22
67 Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998 1.22
68 Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil 2008 1.20
69 Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil 2004 1.19
70 Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology 1990 1.19
71 Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology 1987 1.18
72 Autonomic dysfunction in gastrointestinal motility disorders. Gut 1993 1.18
73 Psychological disorders in patients with evacuation disorders and constipation in a tertiary practice. Am J Gastroenterol 2000 1.18
74 Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci 1986 1.18
75 Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology 1985 1.16
76 Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil 2006 1.15
77 Gastric axial forces in experimentally delayed and accelerated gastric emptying. Am J Physiol 1993 1.15
78 Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst 1994 1.14
79 A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology 1994 1.14
80 Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology 1991 1.14
81 Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil 2009 1.14
82 Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med 1995 1.13
83 Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility. Neurogastroenterol Motil 2005 1.13
84 Mechanisms in IBS: something old, something new, something borrowed... Neurogastroenterol Motil 2005 1.13
85 Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 1995 1.13
86 Chronic intestinal pseudo-obstruction: diagnosis and treatment. Mayo Clin Proc 1989 1.13
87 A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut 2000 1.11
88 Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol 2000 1.11
89 Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther 2010 1.11
90 First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Clin Pharmacol Ther 2009 1.10
91 Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil 2001 1.10
92 Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil 2006 1.09
93 Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology 1986 1.08
94 Adynamic ileus in severe Guillain-Barré syndrome. Muscle Nerve 2001 1.07
95 Motility and tone of the left colon in constipation: a role in clinical practice? Am J Gastroenterol 1996 1.07
96 Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil 2004 1.07
97 Intestinal pseudo-obstruction. Annu Rev Med 1999 1.07
98 Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD). Neurogastroenterol Motil 2012 1.07
99 Coloanal motor coordination in association with high-amplitude colonic contractions after pharmacological stimulation. Am J Gastroenterol 2000 1.06
100 Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil 2002 1.05
101 Brainstem tumor presenting as an upper gut motility disorder. Gastroenterology 1985 1.05
102 Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil 2003 1.05
103 Role of hepatic arterial embolisation in the carcinoid syndrome. Br Med J (Clin Res Ed) 1983 1.05
104 Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1989 1.04
105 Effect of perturbations and a meal on superior mesenteric artery flow in patients with orthostatic hypotension. J Auton Nerv Syst 1997 1.03
106 An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil 2007 1.03
107 Retracted Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003 1.03
108 Does the nutrient drink test accurately predict postprandial gastric volume in health and community dyspepsia? Neurogastroenterol Motil 2005 1.03
109 Rumination syndrome. Mayo Clin Proc 1997 1.02
110 Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil 2008 1.02
111 Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil 2006 1.02
112 Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation. Aliment Pharmacol Ther 2013 1.02
113 Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol 2000 1.02
114 Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging. Neurogastroenterol Motil 2001 1.02
115 Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998 1.01
116 Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther 2002 1.00
117 Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia 2001 1.00
118 Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther 2009 1.00
119 Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Aliment Pharmacol Ther 2000 1.00
120 Vascular anomalies of the gastrointestinal tract. Hepatogastroenterology 1984 1.00
121 SDZ HTF 919 stimulates canine colonic motility and transit in vivo. J Pharmacol Exp Ther 1997 1.00
122 Dose-related effects of chenodeoxycholic acid in the rabbit colon. Dig Dis Sci 1980 0.99
123 Principles of applied neurogastroenterology: physiology/motility-sensation. Gut 1999 0.99
124 Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum 1993 0.99
125 Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes 2001 0.98
126 Control of muscle tone in the human colon. Gut 1992 0.98
127 Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Aliment Pharmacol Ther 2013 0.98
128 Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol 1997 0.97
129 Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil 2008 0.97
130 Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol Ther 2001 0.96
131 The effects of biofeedback on rectal sensation and distal colonic motility in patients with disorders of rectal evacuation: evidence of an inhibitory rectocolonic reflex in humans? Am J Gastroenterol 1999 0.96
132 Rapid gastric emptying in patients with functional diarrhea. Mayo Clin Proc 1997 0.95
133 Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers. Aliment Pharmacol Ther 2009 0.95
134 Thrombophlebitis migrans in ulcerative colitis. Postgrad Med J 1977 0.95
135 Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 1991 0.95
136 Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol 2000 0.95
137 Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond) 2009 0.94
138 Unexplained vomiting: a diagnostic challenge. Ann Intern Med 1984 0.94
139 A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. Am J Gastroenterol 1997 0.94
140 Pseudodominant transmission of fructose intolerance in an adult and three offspring: Heterozygote detection by intestinal biopsy. N Engl J Med 1982 0.93
141 Performance characteristics of the measurement of gastric volume using single photon emission computed tomography. Neurogastroenterol Motil 2011 0.93
142 Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg 2000 0.93
143 On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil 2014 0.93
144 Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology 1991 0.92
145 Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J Clin Gastroenterol 1990 0.92
146 Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer-based and manual linear interpolation models. Neurogastroenterol Motil 2007 0.92
147 Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome. Am J Gastroenterol 1997 0.90
148 Differential regional effects of octreotide on human gastrointestinal motor function. Gut 1995 0.90
149 Malignant histiocytosis and encephalomyeloradiculopathy complicating coeliac disease. Gut 1983 0.90
150 Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2000 0.89
151 Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut 1994 0.89
152 Human gastric and jejunal transit and motility after Roux gastrojejunostomy. Gastroenterology 1992 0.88
153 Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practice. Neurogastroenterol Motil 2013 0.88
154 Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea. Gut 1998 0.88
155 Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterol Motil 2012 0.87
156 Comprehensive assessment of gastric emptying with a stable isotope breath test. Neurogastroenterol Motil 2012 0.87
157 Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity. Neurogastroenterol Motil 2011 0.87
158 Does the ileocolonic junction differentiate between solids and liquids? Gut 1993 0.87
159 Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci 1989 0.87
160 Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Aliment Pharmacol Ther 1993 0.87
161 Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans. Neurogastroenterol Motil 2007 0.87
162 Reduced accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol 1993 0.87
163 Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans. Neurogastroenterol Motil 2007 0.87
164 Pharmacological modulation of rectal tone alters perception of distention in humans. Am J Gastroenterol 1997 0.87
165 Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit. Dig Dis Sci 1997 0.87
166 Dose-related effects of synthetic human beta-endorphin and naloxone on fed gastrointestinal motility. Am J Physiol 1986 0.86
167 Interpretation of overall colonic transit in defecation disorders in males and females. Neurogastroenterol Motil 2013 0.86
168 Effects of an osmotically active agent on colonic transit. Neurogastroenterol Motil 2006 0.86
169 Ileocolonic transit does not change after right hemicolectomy. Gastroenterology 1992 0.86
170 Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil 2006 0.86
171 Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health. Aliment Pharmacol Ther 2003 0.86
172 The current role of erythromycin in the clinical management of gastric emptying disorders. Am J Gastroenterol 1993 0.86
173 The surgeon's role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol 1995 0.85
174 Lupus anticoagulant masquerading as an acute abdomen with multiorgan involvement. Am J Gastroenterol 1995 0.85
175 Pilot study of pathophysiology of constipation among community diabetics. Dig Dis Sci 1998 0.85
176 Systematic review and meta-analysis: does gall-bladder ejection fraction on cholecystokinin cholescintigraphy predict outcome after cholecystectomy in suspected functional biliary pain? Aliment Pharmacol Ther 2003 0.84
177 The ileocecal area and the irritable bowel syndrome. Gastroenterol Clin North Am 1991 0.84
178 Allelic heterogeneity in adult hereditary fructose intolerance. Detection of structural mutations in the aldolase B molecule. Mol Biol Med 1983 0.84
179 A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil 2007 0.84
180 A meta-analysis of immunogenetic Case-Control Association Studies in irritable bowel syndrome. Neurogastroenterol Motil 2015 0.84
181 Functional gastrointestinal disease and the autonomic nervous system: a way ahead? Gastroenterology 1994 0.84
182 Simplifying the measurement of gastric accommodation using SPECT. Neurogastroenterol Motil 2013 0.84
183 Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine. Gut 1981 0.84
184 Pharmacological inhibition of chenodeoxycholate-induced fluid and mucus secretion and mucosal injury in the rabbit colon. Dig Dis Sci 1982 0.84
185 Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill. Gastroenterology 1981 0.84
186 Influence of clinical parameters on the results of 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil 2009 0.83
187 Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action. Gut 1993 0.83
188 Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther 2008 0.83
189 A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Aliment Pharmacol Ther 2012 0.83
190 Measurement of axial forces during emptying from the human stomach. Am J Physiol 1992 0.83
191 Ascending colon response to feeding: evidence for a 5-hydroxytryptamine-3 mechanism. Scand J Gastroenterol 1995 0.83
192 Isolation and characterization of a mutant liver aldolase in adult hereditary fructose intolerance. Identification of the enzyme variant by radioassay in tissue biopsy specimens. J Clin Invest 1983 0.83
193 Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study. Aliment Pharmacol Ther 2006 0.83
194 Effect of age on human gastric and small bowel motility. J Clin Gastroenterol 1989 0.82
195 Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans. Metabolism 1998 0.82
196 Behavioral intervention for the treatment of rumination. J Pediatr Gastroenterol Nutr 1998 0.82
197 Effect of somatovisceral reflexes and selective dermatomal stimulation on postcibal antral pressure activity. Am J Physiol 1984 0.81
198 Therapeutic strategies for motility disorders. Medications, nutrition, biofeedback, and hypnotherapy. Gastroenterol Clin North Am 1996 0.81
199 Embolization of an intrapancreatic aneurysm. Br J Radiol 1982 0.81
200 Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil 2009 0.80
201 Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment Pharmacol Ther 2006 0.80
202 Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride. Neurogastroenterol Motil 2015 0.80
203 Hyperventilation alters colonic motor and sensory function: effects and mechanisms in humans. Gastroenterology 1996 0.80
204 A patient with localized megacolon and intractable constipation: evidence for impairment of colonic muscle tone. Am J Gastroenterol 1994 0.80
205 Measurement of small bowel and colonic transit: indications and methods. Mayo Clin Proc 1992 0.80
206 Use of gastroduodenal manometry to differentiate mechanical and functional intestinal obstruction: an analysis of clinical outcome. Am J Gastroenterol 1994 0.80
207 The fall and rise of the hiatal hernia. Gastroenterology 2000 0.79
208 Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial. Neurogastroenterol Motil 2007 0.79
209 Opiates in the control of gastrointestinal tract function: current knowledge and new avenues for research. Neurogastroenterol Motil 2004 0.79
210 Motilin agonists and dyspepsia: throwing out the baby with the bath water. Gut 2002 0.79
211 Effect of chemical sympathectomy on scintigraphic gastric and small bowel transit in the rat. J Auton Nerv Syst 1992 0.79
212 Influence of H. pylori infection on gastric motor and sensory function in asymptomatic volunteers. Dig Dis Sci 1998 0.79
213 Autonomic control of colonic tone and the cold pressore test. Gut 1996 0.79
214 Gastrointestinal motility considerations in patients with short-bowel syndrome. Dig Dis 1997 0.79
215 Activated charcoal as a potential radioactive marker for gastrointestinal studies. Nucl Med Commun 1998 0.78
216 Effect of acute hyperglycemia on colorectal motor and sensory function in humans. Am J Physiol 1997 0.78
217 Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects. Neurogastroenterol Motil 2008 0.78
218 Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc 1993 0.78
219 The effect of flufenamic acid on gastrointestinal myoelectrical activity and transit time in dogs. Gut 1998 0.78
220 [Clinical management of acute colonic pseudo-obstruction in patients: a systematic review of the literature]. Gastroenterol Hepatol 2003 0.78
221 Noninvasive measurement of human ascending colon volume. Nucl Med Commun 1993 0.78
222 Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology 1989 0.78
223 The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health. Aliment Pharmacol Ther 2010 0.78
224 A pilot study of splenic and whole body retention of autologous radiolabeled leukocytes in the assessment of severity in inflammatory colitis. Am J Gastroenterol 1995 0.78
225 Effect of putative carcinoid mediators on gastric and small bowel transit in rats and the role of 5-HT receptors. Aliment Pharmacol Ther 1993 0.77
226 Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases. Clin Pharmacol Ther 2012 0.77
227 Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004 0.77
228 Dyspepsia is distinguishable from heartburn. Gut 2006 0.77
229 Challenges in drug development for functional gastrointestinal disorders. Part II: visceral pain. Neurogastroenterol Motil 2006 0.77
230 Demonstration of intrathecal and systemic morphine and ST-91 effects on fed canine upper gut motility. Dig Dis Sci 1990 0.77
231 Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers. J Pharmacol Exp Ther 1998 0.77
232 Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers. Neurogastroenterol Motil 2008 0.77
233 Cerebral topography of rectal stimulation using single photon emission computed tomography. Am J Physiol 1999 0.77
234 Functional dyspepsia. Symptoms and underlying mechanism. J Clin Gastroenterol 1986 0.77
235 Alpha 2-adrenergic modulation of colonic tone during hyperventilation. Am J Physiol 1997 0.77
236 Small intestinal motility and transit in disease. Baillieres Clin Gastroenterol 1991 0.77
237 An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 2001 0.77
238 Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia. Neurogastroenterol Motil 2006 0.77
239 Peptidergic and nitrinergic denervation in congenital esophageal stenosis. Gastroenterology 1995 0.76
240 Of actors, bolting horses, and drops in oceans! Gut 2003 0.76
241 Comparison of calculations to estimate gastric emptying half-time of solids in humans. Neurogastroenterol Motil 2012 0.76
242 Ten secrets for development of drugs for functional gastrointestinal diseases. Gastroenterology 2000 0.76
243 Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features. Gastroenterology 1999 0.76
244 Colonic motility and tone after spinal cord and cauda equina injury. Am J Gastroenterol 1997 0.76
245 Cystic lymphangioma of the colon. Endoscopic and histologic features. Dis Colon Rectum 1983 0.76
246 Unprepared human colon does not discriminate between solids and liquids. Am J Physiol 1991 0.76
247 Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background. Lupus 2010 0.76
248 Will a NaH14CO3-capsule method accurately measure gastric emptying? Am J Gastroenterol 1993 0.75
249 Recurrent vomiting following Harrington rod instrumentation of the spine. J Pediatr Gastroenterol Nutr 1996 0.75
250 Small bowel manometry. Dig Dis Sci 1997 0.75
251 Intestinal dysmotility: does the X-ray resolve the real dilemma? J Pediatr Gastroenterol Nutr 1997 0.75
252 Sensations of gas and pain and their relationship with compliance during distension in human colon. Neurogastroenterol Motil 2012 0.75
253 Postprandial function in gastroparesis. Gut 1995 0.75
254 Irritable bowel syndrome. Lancet 1993 0.75
255 What's in a name? Roll on Rome II. Gastroenterology 1998 0.75
256 Candidate genes and functional dyspepsia. Neurogastroenterol Motil 2009 0.75
257 Diabetic diarrhea. Semin Gastrointest Dis 1995 0.75
258 Antroduodenal manometry. Dig Dis Sci 1992 0.75
259 Antroduodenal coordination and solid lag phase. Gastroenterology 1988 0.75
260 Neurogastroenterology and motility: new millenium, new horizons. Neurogastroenterol Motil 2001 0.75
261 Role of bile acids in the pathogenesis of diarrhoea in various diseases. Acta Gastroenterol Belg 1981 0.75
262 Relation between fat malabsorption and transit abnormalities in human carcinoid diarrhea. Gastroenterology 1996 0.75
263 The metamorphosis of motility: from squiggles to neuroscience. Gastroenterology 1997 0.75
264 Postapproval drug surveillance and the first principle of medicine. Gastroenterology 2001 0.75
265 Antral axial forces postprandially and after erythromycin in organic and functional dysmotilities. Dig Dis Sci 1996 0.75
266 Olestra, a nondigestible, nonabsorbable fat. Effects on gastrointestinal and colonic transit. Dig Dis Sci 1993 0.75
267 Best of DDW 2001. Highlights from the 2001 Digestive Disease Week. May 20-23, 2001, Atlanta, GA. Rev Gastroenterol Disord 2001 0.75
268 Audit of suspected chronic intestinal pseudo-obstruction in patients with gynecologic cancer. Eur J Gynaecol Oncol 2008 0.75
269 Nonulcer dyspepsia. Gastroenterologist 1996 0.75
270 Colectomy for severe constipation. Dig Dis Sci 1988 0.75
271 Recent developments in workers' compensation law. Tort Insur Law J 1998 0.75
272 New therapies for functional bowel diseases. Curr Gastroenterol Rep 2000 0.75
273 [Transit of solids through the human colon: simplification of a technique]. Gastroenterol Clin Biol 1992 0.75
274 Halothane aggravation of chronic liver disease. Acta Med Port 1984 0.75
275 Organic basis for symptoms in functional gastrointestinal disease? Mayo Clin Proc 1988 0.75
276 Functional abdominal pain in the elderly. Gastroenterol Clin North Am 2001 0.75
277 111In-oxine-labelled granulocyte dosimetry in normal subjects. Nucl Med Commun 1995 0.75
278 Subtle hyperthyroidism presenting as suspected hepatobiliary disease. J Clin Gastroenterol 1987 0.75
279 Duodenal obstruction: diagnosis by gastroduodenal manometry. Mayo Clin Proc 1997 0.75
280 On the threshold of translating basic enteric neuroscience advances. Gastroenterology 1999 0.75